{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT03897881",
            "orgStudyIdInfo": {
                "id": "mRNA-4157-P201"
            },
            "organization": {
                "fullName": "ModernaTX, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Participants With High-Risk Melanoma (KEYNOTE-942)",
            "officialTitle": "A Phase 2 Randomized Study of Adjuvant Immunotherapy With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab Versus Pembrolizumab Alone After Complete Resection of High-Risk Melanoma (KEYNOTE- 942)",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "an-efficacy-study-of-adjuvant-treatment-with-the-personalized-cancer-vaccine-mrna-and-pembrolizumab-in-participants-with-high-risk-melanoma-keynote"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2019-07-18",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2029-09-09",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2029-09-09",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2019-03-29",
            "studyFirstSubmitQcDate": "2019-03-29",
            "studyFirstPostDateStruct": {
                "date": "2019-04-01",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-31",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-03",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "ModernaTX, Inc.",
                "class": "INDUSTRY"
            },
            "collaborators": [
                {
                    "name": "Merck Sharp & Dohme LLC",
                    "class": "INDUSTRY"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to assess whether postoperative adjuvant therapy with mRNA-4157 and pembrolizumab improves recurrence free survival (RFS) compared to pembrolizumab alone in participants with complete resection of cutaneous melanoma and a high risk of recurrence."
        },
        "conditionsModule": {
            "conditions": [
                "Melanoma"
            ],
            "keywords": [
                "mRNA-4157",
                "Individualized Neoantigen Therapy",
                "INT",
                "Pembrolizumab",
                "Moderna"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE",
                    "maskingDescription": "Open Label"
                }
            },
            "enrollmentInfo": {
                "count": 267,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "mRNA-4157 and Pembrolizumab",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive up to 9 doses of mRNA-4157 (every 21 days). Participants may continue on pembrolizumab (every 21 days) until disease recurrence, unacceptable toxicity, or they undergo up to 18 total cycles (approximately 1 year of treatment), whichever is sooner.",
                    "interventionNames": [
                        "Drug: mRNA-4157",
                        "Biological: Pembrolizumab"
                    ]
                },
                {
                    "label": "Pembrolizumab",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Participants will receive pembrolizumab (every 21 days) until disease recurrence, unacceptable toxicity, or they undergo up to 18 total cycles (approximately 1 year of treatment), whichever is sooner.",
                    "interventionNames": [
                        "Biological: Pembrolizumab"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "mRNA-4157",
                    "description": "Individualized Neoantigen Therapy",
                    "armGroupLabels": [
                        "mRNA-4157 and Pembrolizumab"
                    ]
                },
                {
                    "type": "BIOLOGICAL",
                    "name": "Pembrolizumab",
                    "description": "Intravenous infusion",
                    "armGroupLabels": [
                        "Pembrolizumab",
                        "mRNA-4157 and Pembrolizumab"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Recurrence-Free Survival (RFS), Assessed Using Radiological Imaging",
                    "description": "RFS is defined as the time between the date of first dose of pembrolizumab and the date of recurrence (local, regional, or distant metastasis), new primary melanoma, or death (whatever the cause), whichever occurs first.",
                    "timeFrame": "Up to 5 years"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Distant Metastasis-Free Survival (DMFS), Assessed Using Radiological Imaging",
                    "description": "DMFS is defined as the time between the date of first dose of pembrolizumab and the date of the first distant metastasis or the date of death (whatever the cause), whichever occurs first.",
                    "timeFrame": "Up to 5 years"
                },
                {
                    "measure": "Number of Participants With Adverse Events (AEs)",
                    "timeFrame": "Baseline through 100 days after last mRNA-4157 dose (for mRNA-4157 and Pembrolizumab combination arm) and up to 90 days after last pembrolizumab dose (for Pembrolizumab only arm) (up to a total of 5 years for both arms)"
                },
                {
                    "measure": "Number of Participants Who Discontinued Due to AEs",
                    "timeFrame": "Baseline through 100 days after last mRNA-4157 dose (for mRNA-4157 and Pembrolizumab combination arm) and up to 90 days after last pembrolizumab dose (for Pembrolizumab only arm) (up to a total of 5 years for both arms)"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Key Inclusion Criteria:\n\n* Resectable cutaneous melanoma metastatic to a lymph node and at high risk of recurrence\n* Complete resection within 13 weeks prior to the first dose of pembrolizumab\n* Disease free at study entry (after surgery) with no loco-regional relapse or distant metastasis and no clinical evidence of brain metastases\n* Has an formalin fixed paraffin embedded (FFPE) tumor sample available suitable for sequencing\n* Eastern Cooperative Oncology Group (ECOG) Performance Status 0 or 1\n* Normal organ and marrow function reported at screening\n\nKey Exclusion Criteria:\n\n* Prior malignancy, unless no evidence of that disease for at least 5 years prior to study entry\n* Prior systemic anti-cancer treatment (except surgery and interferon for thick primary melanomas. Radiotherapy after lymph node dissection is permitted)\n* Live vaccine within 30 days prior to the first dose of pembrolizumab\n* Transfusion of blood or administration of colony stimulating factors within 2 weeks of the screening blood sample\n* Active autoimmune disease\n* Immunodeficiency, systemic steroid therapy, or any other immunosuppressive therapy within 7 days prior to the first dose of pembrolizumab\n* Solid organ or allogeneic bone marrow transplant\n* Pneumonitis or a history of (noninfectious) pneumonitis that required steroids\n* Prior interstitial lung disease\n* Clinically significant heart failure\n* Known history of human immunodeficiency virus (HIV)\n* Known active hepatitis B or C\n* Active infection requiring treatment",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Moderna Clinical Trials Support Center",
                    "role": "CONTACT",
                    "phone": "1-877-777-7187",
                    "email": "clinicaltrials@modernatx.com"
                }
            ],
            "locations": [
                {
                    "facility": "University of Arizona",
                    "status": "RECRUITING",
                    "city": "Tucson",
                    "state": "Arizona",
                    "zip": "85719",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Montaser Shaheen",
                            "role": "CONTACT",
                            "phone": "812-230-1521",
                            "email": "shaheenm@email.arizona.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.22174,
                        "lon": -110.92648
                    }
                },
                {
                    "facility": "California Pacific Medical Center Research Institute -CPMCRI",
                    "status": "RECRUITING",
                    "city": "San Francisco",
                    "state": "California",
                    "zip": "94115",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Kevin Kim, MD",
                            "role": "CONTACT",
                            "phone": "415-885-8600",
                            "email": "kimkb@sutterhealth.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.77493,
                        "lon": -122.41942
                    }
                },
                {
                    "facility": "Angeles Clinic and Research Institute",
                    "status": "RECRUITING",
                    "city": "Santa Monica",
                    "state": "California",
                    "zip": "90404",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Mark Faries, MD",
                            "role": "CONTACT",
                            "phone": "310-582-7020",
                            "email": "mfaries@theangelesclinic.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.01945,
                        "lon": -118.49119
                    }
                },
                {
                    "facility": "University of Colorado Cancer Center",
                    "status": "RECRUITING",
                    "city": "Aurora",
                    "state": "Colorado",
                    "zip": "80045",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Karl Lewis, MD",
                            "role": "CONTACT",
                            "phone": "720-848-0637",
                            "email": "karl.lewis@ucdenver.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.72943,
                        "lon": -104.83192
                    }
                },
                {
                    "facility": "Smilow Cancer Center at Yale New Haven Hospital",
                    "status": "RECRUITING",
                    "city": "New Haven",
                    "state": "Connecticut",
                    "zip": "06520",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Sarah Weiss, MD",
                            "role": "CONTACT",
                            "phone": "203-785-6378",
                            "email": "sarah.weiss.sw842@yale.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.30815,
                        "lon": -72.92816
                    }
                },
                {
                    "facility": "Lombardi Cancer Center",
                    "status": "RECRUITING",
                    "city": "Washington",
                    "state": "District of Columbia",
                    "zip": "20007",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Geoffrey Gibney, MD",
                            "role": "CONTACT",
                            "phone": "813-745-3437",
                            "email": "geoffrey.t.gibney@gunet.georgetown.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.89511,
                        "lon": -77.03637
                    }
                },
                {
                    "facility": "Orlando Health UF Health Cancer Center",
                    "status": "RECRUITING",
                    "city": "Orlando",
                    "state": "Florida",
                    "zip": "32806",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Sajeve Thomas",
                            "role": "CONTACT",
                            "phone": "954-663-7551",
                            "email": "Sajeve.thomas@orlandohealth.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 28.53834,
                        "lon": -81.37924
                    }
                },
                {
                    "facility": "UPMC Hillman Cancer Center",
                    "status": "RECRUITING",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60637",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jason Luke",
                            "role": "CONTACT",
                            "phone": "773-702-0963",
                            "email": "lukejj@upmc.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                },
                {
                    "facility": "Massachusetts General Hospital",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02114",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ryan Sullivan, MD",
                            "role": "CONTACT",
                            "phone": "617-632-5470",
                            "email": "rsullivan7@mgh.harvard.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Dana Farber Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02115",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Elizabeth Buckbinder",
                            "role": "CONTACT",
                            "phone": "617-632-9271",
                            "email": "elizabeth_buckbinder@dfci.harvard.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Washington University School of Medicine",
                    "status": "RECRUITING",
                    "city": "Saint Louis",
                    "state": "Missouri",
                    "zip": "63110",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Leonel Hernandez Aya, MD",
                            "role": "CONTACT",
                            "phone": "314-747-7510",
                            "email": "lhernand@dom.wustl.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.62727,
                        "lon": -90.19789
                    }
                },
                {
                    "facility": "Hackensack University Medical Center",
                    "status": "RECRUITING",
                    "city": "Hackensack",
                    "state": "New Jersey",
                    "zip": "07601",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Andrew Pecora, MD",
                            "role": "CONTACT",
                            "phone": "551-996-5814",
                            "email": "andrew.pecora@hackensackmeridian.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.88593,
                        "lon": -74.04347
                    }
                },
                {
                    "facility": "NYU Langone Medical Center",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10016",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jeffrey Weber, MD",
                            "role": "CONTACT",
                            "phone": "212-731-6262",
                            "email": "jeffrey.weber@nyumc.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Providence Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Portland",
                    "state": "Oregon",
                    "zip": "97213",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Mathew Taylor",
                            "role": "CONTACT",
                            "phone": "503-494-8534",
                            "email": "matthew.taylor@providence.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.52345,
                        "lon": -122.67621
                    }
                },
                {
                    "facility": "Sarah Cannon Cancer Center",
                    "status": "RECRUITING",
                    "city": "Nashville",
                    "state": "Tennessee",
                    "zip": "37203",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Meredith McKean, MD",
                            "role": "CONTACT",
                            "phone": "615-329-7274",
                            "email": "mmckean@tnonc.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.16589,
                        "lon": -86.78444
                    }
                },
                {
                    "facility": "Texas Oncology PA",
                    "status": "RECRUITING",
                    "city": "Dallas",
                    "state": "Texas",
                    "zip": "75246",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Charles Cowey, MD",
                            "role": "CONTACT",
                            "phone": "214-370-1000",
                            "email": "lance.cowey@usoncology.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.78306,
                        "lon": -96.80667
                    }
                },
                {
                    "facility": "Melanoma Institute Australia",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "North Sydney",
                    "state": "New South Wales",
                    "zip": "2060",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -33.839,
                        "lon": 151.2072
                    }
                },
                {
                    "facility": "Westmead Hospital",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Westmead",
                    "state": "New South Wales",
                    "zip": "2145",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -33.80383,
                        "lon": 150.98768
                    }
                },
                {
                    "facility": "Princess Alexandra Hospital",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Woolloongabba",
                    "state": "Queensland",
                    "zip": "4102",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -27.48855,
                        "lon": 153.03655
                    }
                },
                {
                    "facility": "Affinity Clinical Research",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Murdoch",
                    "state": "Western Australia",
                    "zip": "6150",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -32.06987,
                        "lon": 115.83757
                    }
                },
                {
                    "facility": "St John of God Hospital Subiaco",
                    "status": "RECRUITING",
                    "city": "Subiaco",
                    "state": "Western Australia",
                    "zip": "6008",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Tarek Meniawy",
                            "role": "CONTACT",
                            "phone": "+61861023640",
                            "email": "tarek@westernoncology.com.au"
                        }
                    ],
                    "geoPoint": {
                        "lat": -31.9485,
                        "lon": 115.8268
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008545",
                    "term": "Melanoma"
                }
            ],
            "ancestors": [
                {
                    "id": "D000018358",
                    "term": "Neuroendocrine Tumors"
                },
                {
                    "id": "D000017599",
                    "term": "Neuroectodermal Tumors"
                },
                {
                    "id": "D000009373",
                    "term": "Neoplasms, Germ Cell and Embryonal"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000009380",
                    "term": "Neoplasms, Nerve Tissue"
                },
                {
                    "id": "D000018326",
                    "term": "Nevi and Melanomas"
                },
                {
                    "id": "D000012878",
                    "term": "Skin Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M11528",
                    "name": "Melanoma",
                    "asFound": "Melanoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M20495",
                    "name": "Neuroendocrine Tumors",
                    "relevance": "LOW"
                },
                {
                    "id": "M19845",
                    "name": "Neuroectodermal Tumors",
                    "relevance": "LOW"
                },
                {
                    "id": "M20388",
                    "name": "Neuroectodermal Tumors, Primitive",
                    "relevance": "LOW"
                },
                {
                    "id": "M12318",
                    "name": "Neoplasms, Germ Cell and Embryonal",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M12325",
                    "name": "Neoplasms, Nerve Tissue",
                    "relevance": "LOW"
                },
                {
                    "id": "M12448",
                    "name": "Nevus, Pigmented",
                    "relevance": "LOW"
                },
                {
                    "id": "M12446",
                    "name": "Nevus",
                    "relevance": "LOW"
                },
                {
                    "id": "M20470",
                    "name": "Nevi and Melanomas",
                    "relevance": "LOW"
                },
                {
                    "id": "M15681",
                    "name": "Skin Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T4091",
                    "name": "Neuroendocrine Tumor",
                    "relevance": "LOW"
                },
                {
                    "id": "T4092",
                    "name": "Neuroepithelioma",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000582435",
                    "term": "Pembrolizumab"
                }
            ],
            "ancestors": [
                {
                    "id": "D000074322",
                    "term": "Antineoplastic Agents, Immunological"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000082082",
                    "term": "Immune Checkpoint Inhibitors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M349416",
                    "name": "Pembrolizumab",
                    "asFound": "Mg/m2",
                    "relevance": "HIGH"
                },
                {
                    "id": "M2853",
                    "name": "Immunomodulating Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M17360",
                    "name": "Vaccines",
                    "relevance": "LOW"
                },
                {
                    "id": "M1346",
                    "name": "Antineoplastic Agents, Immunological",
                    "relevance": "LOW"
                },
                {
                    "id": "M2342",
                    "name": "Immune Checkpoint Inhibitors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}